- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
B cell treatments for multiple sclerosis ; day:4 ; month:3 ; year:2017 ; pages:1-3
Journal of neurology ; (4.3.2017), 1-3
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Urheber
-
McLauchlan, D.
- Beteiligte Personen und Organisationen
-
Robertson, N. P.
SpringerLink (Online service)
- DOI
-
10.1007/s00415-017-8442-y
- URN
-
urn:nbn:de:1111-201703259838
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- McLauchlan, D.
- Robertson, N. P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Early indicators, early treatments, neuroprotection in multiple sclerosis
Update on multiple sclerosis, its diagnosis and treatments
Cost Assessment Modelling of Treatments for Highly Active Relapsing Multiple Sclerosis
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
Stem cell treatment for multiple sclerosis
Cognitive Efficacy of Pharmacologic Treatments in Multiple Sclerosis: A Systematic Review
Alemtuzumab for Multiple Sclerosis
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment
Multiple sclerosis
Multiple sclerosis
Fingolimod Therapy for Multiple Sclerosis
Peripheral immune cell signatures in multiple sclerosis
Early indicators, early treatments, neuroprotection in multiple sclerosis
Update on multiple sclerosis, its diagnosis and treatments
Cost Assessment Modelling of Treatments for Highly Active Relapsing Multiple Sclerosis
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
Stem cell treatment for multiple sclerosis
Cognitive Efficacy of Pharmacologic Treatments in Multiple Sclerosis: A Systematic Review
Alemtuzumab for Multiple Sclerosis
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment
Multiple sclerosis
Multiple sclerosis
Fingolimod Therapy for Multiple Sclerosis
Peripheral immune cell signatures in multiple sclerosis
Early indicators, early treatments, neuroprotection in multiple sclerosis
Update on multiple sclerosis, its diagnosis and treatments
Cost Assessment Modelling of Treatments for Highly Active Relapsing Multiple Sclerosis
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
Stem cell treatment for multiple sclerosis
Cognitive Efficacy of Pharmacologic Treatments in Multiple Sclerosis: A Systematic Review
Alemtuzumab for Multiple Sclerosis
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment
Multiple sclerosis
Multiple sclerosis
Fingolimod Therapy for Multiple Sclerosis